How can we improve breast cancer treatment?
Despite significant advancements, challenges persist in translating cutting-edge research into personalized care, especially for underserved populations and patients with aggressive subtypes.
This webinar brings together a panel of cross-disciplinary experts to explore how artificial intelligence and precision medicine are reshaping the future of breast cancer treatment.
Guest Speakers:
๐๐ฒ๐๐๐ถ๐ฐ๐ฐ๐ฎ ๐ฅ๐ฒ๐ด๐ฒ, a drug developer, will address the challenges posed by the overwhelming volume of clinical trial data and how it affects physiciansโ ability to make timely, informed treatment decisions.
๐ฆ๐ต๐ฎ๐ป๐ถ๐๐ฒ ๐ฃ๐ฒ๐ฎ๐ฟ๐ฐ๐ฒ, a triple negative breast cancer survivor and advocate, shares her perspective on the current gaps in breast cancer treatment and how patients are becoming more empowered and involved in their care decisions.
๐๐ฟ. ๐ ๐ฒ๐ต๐ฟ๐ฎ๐ป ๐๐ฎ๐ฏ๐ถ๐ฏ๐ถ, a breast cancer surgeon, discusses the potential of AI applications in surgical oncology and patient care.
๐๐ป๐ป๐ฎ ๐๐ผ๐ฟ๐๐๐๐ต๐ฒ, a pharmacist and health economist, discusses the limitations of relying solely on generative AI and emphasize the critical role of expert human curation. Sheโll also introduce Oncoscope-AI, a real-time oncology library that integrates scientific evidence from diverse sources to support informed, evidence-based treatment decisions at the point of care.
This multidisciplinary discussion explores how the convergence of patient advocacy, clinical expertise, and technological innovation can drive more effective and personalized approaches to breast cancer treatment. The speakers highlight current applications and future opportunities for AI in oncology, focusing on practical, real-world solutions that can improve patient care today.
Watch the fulll webinar here:
Beka Vinogradov is the Digital Communications Lead for Oncoscope-AI. She holds a Masterโs in Health Administration and has extensive experience and education in business, marketing, and design.
